BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Metabolic Pharmaceuticals Limited 

Level 3, 509 St. Kilda Road

Melbourne  Victoria  3004  Australia
Phone: 61-3-9860-5700 Fax: 61-3-9860-5777


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Metabolic Pharmaceuticals (MBP.AX) Denies Soccer Players Were Part of Secret Drug Trial 7/29/2013 8:50:02 AM
Metabolic Pharmaceuticals (MBP.AX)'s Obesity Trial Update: First 100 Subjects Complete The Phase 2B Trial Of AOD9604 10/5/2006 11:26:05 AM
Metabolic Pharmaceuticals (MBP.AX)'s Neuropathic Pain Drug, ACV1, Enters Phase 2 Clinical Trials 9/28/2006 11:20:32 AM
Metabolic Pharmaceuticals (MBP.AX) To Present At The Rodman & Renshaw Techvest 7th Annual Healthcare Conference 11/3/2005 11:51:38 AM
Metabolic Pharmaceuticals (MBP.AX) Initiates Recruitment For Phase II-B Clinical Trial Of AOD9604 Obesity Drug10/19/2005 5:13:22 PM
Neuren Pharmaceuticals Limited And Metabolic Pharmaceuticals (MBP.AX) Collaborate To Develop Range Of Nerve Repair Compounds With Support From New Zealand Government10/19/2005 5:12:56 PM
Metabolic Pharmaceuticals (MBP.AX) Appoints New Chief Executive Officer10/19/2005 5:12:32 PM
Metabolic Pharmaceuticals (MBP.AX) Shares Partnering Prospects For AOD9604 For Obesity10/19/2005 5:12:30 PM
Metabolic Pharmaceuticals (MBP.AX) Reports Positive Results From Its Phase 2b Obesity Trial; Fat Burning Pill Effective10/19/2005 5:12:26 PM
Metabolic Pharmaceuticals (MBP.AX) , Circadian Technologies Limited (CIR.AX) Trading Halted Ahead Of Trial Results10/19/2005 5:12:25 PM
12